Home › NDC Lookup › RxCUI directory › RxCUI 310247

24 HR etodolac 600 MG Extended Release Oral Tablet — RxCUI 310247

RxNorm drug concept · Semantic clinical drug
RxCUI 310247 Semantic clinical drug · SCD ● Current RxNorm concept 21 FDA products 62 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310247
Official name24 HR etodolac 600 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asetodolac 600 MG 24HR Extended Release Oral Tablet
FDA products mapped21
Package NDCs mapped62
Reported Medicaid activity (SDUD)805 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Etodolac: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Etodolac is used to treat the pain and inflammation of osteoarthritis and rheumatoid arthritis. The capsule and tablet forms are also approved for short-term acute pain. The extend...
  • You can take etodolac with or without food — food doesn't significantly change the total amount your body absorbs. That said, if etodolac irritates your stomach, taking it with foo...
  • The most common side effects are stomach-related — nausea, heartburn, diarrhea, or abdominal discomfort — along with dizziness, headache, and ringing in the ears. Most are mild. Th...
  • What side effects should I actually watch out for?
📖 Read our full Etodolac guide →

🕸️ Concept Web — How 24 HR etodolac 600 MG Extended Release Oral Tabl... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR etodolac 600 MG Extended Release Oral Tablet RxCUI 310247

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Etodolac 24605
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Etodolac Extended Release Oral Tablet 379169
    • Etodolac Oral Product 1157924
    • Etodolac Pill 1157925
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Etodolac 600 MG 315910

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Etodolac 600 MG SCDC · 315910
  • Etodolac Extended Release Oral Tablet SCDF · 379169
  • Etodolac Oral Product SCDG · 1157924
  • Etodolac Pill SCDG · 1157925

📦 FDA Products & Package NDCs

21 products · 62 package NDCs
62 package NDCs map to RxCUI 310247 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68382-0272-05 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382... Etodolac Zydus Pharmaceuticals USA Inc. 2014-02-15
68382-0272-10 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (6838... Etodolac Zydus Pharmaceuticals USA Inc. 2014-02-15
68382-0272-14 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-... Etodolac Zydus Pharmaceuticals USA Inc. 2014-02-15
68382-0272-77 100 BLISTER PACK in 1 CARTON (68382-272-77) / 1 TABLET, FIL... Etodolac Zydus Pharmaceuticals USA Inc. 2014-02-15
68382-0273-01 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382... Etodolac Zydus Pharmaceuticals USA Inc. 2014-02-15
68382-0273-05 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382... Etodolac Zydus Pharmaceuticals USA Inc. 2014-02-15
68382-0273-10 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (6838... Etodolac Zydus Pharmaceuticals USA Inc. 2014-02-15
68382-0273-14 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-... Etodolac Zydus Pharmaceuticals USA Inc. 2014-02-15
68382-0273-77 100 BLISTER PACK in 1 CARTON (68382-273-77) / 1 TABLET, FIL... Etodolac Zydus Pharmaceuticals USA Inc. 2014-02-15
80425-0126-01 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0126-1) Etodolac ER Advanced Rx Pharmacy of Tennessee, LLC 2003-03-13
80425-0181-01 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0181-1) Etodolac ER Advanced Rx Pharmacy of Tennessee, LLC 2003-03-13
80425-0381-01 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (80425-... Etodolac Advanced Rx Pharmacy of Tennessee, LLC 2024-04-10
Observed labelers: Taro Pharmaceuticals U.S.A., Inc. (18) · Zydus Lifesciences Limited (15) · Zydus Pharmaceuticals USA Inc. (15) · NORTHSTAR RX LLC (5) · Advanced Rx Pharmacy of Tennessee, LLC (3) · Teva Pharmaceuticals USA, Inc. (3) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.